Form D · Other Investment Fund

Eversept Global Healthcare Fund, LP

New York, NY · CIK 0001516606

Offering snapshot reported Oct 15, 2026 · SEC filing

Reported sold
$1.31B
Indefinite offering
Investors reported
382
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 21, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$657M$1.31BApr 15, 2011: $1,700,000.00Apr 15, 2011Apr 23, 2012: $4,000,000.00Jul 23, 2013: $4,000,000.00Jul 22, 2014: $4,000,000.00Dec 2, 2015: $17,491,888.00Nov 4, 2016: $23,216,887.00Nov 2, 2017: $70,066,889.00Nov 2, 2018: $103,911,889.00Oct 31, 2019: $197,640,909.00Oct 30, 2020: $385,240,487.00Oct 29, 2021: $877,272,171.00Oct 31, 2022: $981,706,099.00Oct 24, 2023: $1,008,191,099.00Oct 15, 2024: $1,105,762,173.00Oct 15, 2025: $1,232,420,673.00Oct 15, 2026: $1,314,485,673.00Oct 15, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,232,420,673 → $1,314,485,673
  • Reported investors354 → 382

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 15, 2026Amendment$1,314,485,673$82,065,000vs Oct 15, 2025382SEC filing
Oct 15, 2025Amendment$1,232,420,673$126,658,500vs Oct 15, 2024354SEC filing
Oct 15, 2024Amendment$1,105,762,173$97,571,074vs Oct 24, 2023297SEC filing
Oct 24, 2023Amendment$1,008,191,099$26,485,000vs Oct 31, 2022264SEC filing
Oct 31, 2022Amendment$981,706,099$104,433,928vs Oct 29, 2021201SEC filing
Oct 29, 2021Amendment$877,272,171$492,031,684vs Oct 30, 2020113SEC filing
Oct 30, 2020Amendment$385,240,487$187,599,578vs Oct 31, 2019101SEC filing
Oct 31, 2019Amendment$197,640,909$93,729,020vs Nov 2, 201864SEC filing
Nov 2, 2018Amendment$103,911,889$33,845,000vs Nov 2, 201748SEC filing
Nov 2, 2017Amendment$70,066,889$46,850,002vs Nov 4, 201640SEC filing
Nov 4, 2016Amendment$23,216,887$5,724,999vs Dec 2, 201516SEC filing
Dec 2, 2015Amendment$17,491,888$13,491,888vs Jul 22, 20149SEC filing
Jul 22, 2014Amendment$4,000,000$0vs Jul 23, 20138SEC filing
Jul 23, 2013Amendment$4,000,000$0vs Apr 23, 20128SEC filing
Apr 23, 2012Amendment$4,000,000$2,300,000vs Apr 15, 20118SEC filing
Apr 15, 2011Initial$1,700,000No comparison2SEC filing

Offering details

Securities
Pooled investment fund, Other
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$1.34M
Finders' fees
$0
Form D file number
021-158466
Limited Partnership Interests
Clarification to Item 12, Gallatin Capital LLC is no longer in a marketing agreement with the Issuer, in connection with sales of securities in the offering.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
-NoneMerrill Lynch, Pierce, Fenner & Smith Incorporated · CRD 7691

Source: Form D, filed Oct 15, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

EVERSEPT GLOBAL HEALTHCARE FUND, LP

Investment adviser: EVERSEPT PARTNERS, L.P.

Gross asset value
$1.75B
Beneficial owners
415
ADV minimum commitment
$100K

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator MORGAN STANLEY FUND SERVICES (CAYMAN) LTD. GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No
Fund administrator MORGAN STANLEY FUND SERVICES USA LLC PURCHASE, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor ERNST & YOUNG LLP NEW YORK, New York, United States
Auditor ERNST & YOUNG LTD. GEORGE TOWN, GRAND CAYMAN, Cayman Islands
Custodian J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No
Custodian MORGAN STANLEY & CO. LLC NEW YORK, New York, United States Related to adviser: No
Custodian NORTHERN TRUST INTERNATIONAL BANKING CORPORATION JERSEY CITY, New Jersey, United States Related to adviser: No
Marketer ALP ALBER ARDITI ISTANBUL, Turkey Related to adviser: No
Marketer IVP CAPITAL, LLC WATER MILL, New York, United States Related to adviser: No
Marketer MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Prime broker J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States
Prime broker MORGAN STANLEY & CO. LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

ERNST & YOUNG LLP
PCAOB 42

ERNST & YOUNG LTD.
PCAOB 1655

J.P. MORGAN SECURITIES LLC
SEC 8-35008

MORGAN STANLEY & CO. LLC
SEC 8-15869

IVP CAPITAL, LLC
CRD 104197 · SEC 8-52663

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
CRD 7691 · SEC 801-14235

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 8-35008

MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869

Filing source

Form ADV 2064990 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-9357951688

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Apis Capital Advisors, Llc Promoter
Eversept Gp, Llc Promoter
Eversept Gp, L.L.C. Executive
Eversept Gp, Lp Executive
Eversept Partners, Llc Promoter
Eversept Partners, Lp Promoter
Kamran Moghtaderi Executive
N/A Parsimony Investments Gp, Llc Executive
Yue "Derrick" Tang Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
444 Madison Avenue, 22 Nd Floor
New York, NY, 10022